VLG

Venture Life Group PLC

Personal Care, Drug and Grocery Stores First-pass screen £70m

340/1000 Overall fit

AI beneficiary 35% 20

Operating leverage 25% 55

Valuation 25% 30

Downside protection 15% 38

First-pass take

Consumer healthcare (supplements, medical devices) with no AI exposure or strategy. Gross margin improved 4.2ppts to 45.8%, revenue +18.9%, but gains stem from product innovation and marketing spend, not operational leverage. Constrained by high customer concentration (Amazon+Bayer = 29% of continuing revenue) and net debt £20.1m at 1.83x leverage.

Flags

no-ai-exposureno-valuation-datacustomer-concentrationnet-debtelevated-leveragemicro-cappost-m-and-arestructuring